Matica Biotechnology (Matica Bio), a leading contract development and manufacturing organization (CDMO) specializing in viral ...

VIVEbiotech, a leading lentiviral vector Contract Development and Manufacturing Organization (CDMO), today announced a growth ...

TASS/. Mass vaccination with a coronavirus vaccine developed by Russia’s State Research Center of Virology and Biotechnology Vector is expected to take place in 2021, the center's Director ...

To develop the next generation of in vivo T cell therapy, Novartis will leverage Vyriad's active targeting lentiviral vector ...

Development of super-infective ternary vector systems for enhancing the Agrobacterium-mediated plant transformation and ...

MILAN, Dec. 03, 2024 (GLOBE NEWSWIRE) -- AAVantgarde Bio (AAVantgarde), a clinical-stage, Italian-based international biotechnology company with two proprietary Adeno-Associated Viral (AAV) vector ...

Matica Biotechnology, Inc. (Matica Bio), a CDMO specializing in viral vector development and manufacturing, today announced the appointment of Min Par ...

This project builds on recent work reporting tick transmission of relapsing fever spirochetes and genome sequencing of both the pathogen and tick vector. We have utilized both next generation and ...